[{"trial_id":32,"discovery_date":"2021-03-29T11:19:37","title":"Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis (MS)&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Procedure: SC MRI;   Other: patient questionnaire&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    University Hospital, Basel, Switzerland;   Freie Akademische Gesellschaft Basel&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04819737?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-29T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":31,"discovery_date":"2021-03-29T11:19:36","title":"Study of the Mechanisms of Action of Cladribine in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: biological collection&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    University Hospital, Rouen&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04821596?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-29T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":30,"discovery_date":"2021-03-26T13:30:35","title":"Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Urinary Bladder, Neurogenic;   Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: VESIcare 10Mg Tablet;   Drug: Botox 100 UNT Injection&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Brigitte Schürch;   Centre Hospitalier Universitaire Vaudois&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04819360?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-26T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":29,"discovery_date":"2021-03-26T13:30:35","title":"The Effect of the Arabic Otago Exercise Program on Falls in People With Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Otago Exercise Program&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    University of Jordan&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04818008?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-26T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":28,"discovery_date":"2021-03-25T11:16:53","title":"Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Spasticity;   Cerebrovascular Accident;   Multiple Sclerosis;   Traumatic Brain Injury;   Cervical Spinal Cord Injury;   Cerebral Palsy&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: rimabotulinumtoxinB;   Drug: Placebo&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Supernus Pharmaceuticals, Inc.&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04815967?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-25T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":27,"discovery_date":"2021-03-19T11:55:20","title":"Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients With Multiple Sclerosis MS-NEUROPLAST","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Cognitive Decline&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Cognitive Training&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Aristotle University Of Thessaloniki;   King Fahad Medical City&lt;br&#x2F;&gt;&lt;b&gt;Active, not recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04806568?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-19T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":26,"discovery_date":"2021-03-19T11:55:20","title":"Virtual Reality in Physical Therapy in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Device: Neuroproprioceptive &quot;facilitation and inhibition&quot; in virtual reality;   Other: Neuroproprioceptive &quot;facilitation and inhibition&quot;&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Charles University, Czech Republic&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04807738?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-19T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":25,"discovery_date":"2021-03-19T11:55:20","title":"Nature of the Link Between Executive Functions and Theory of Mind in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Theory of Mind&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Lille Catholic University&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04806217?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-19T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":24,"discovery_date":"2021-03-18T11:23:53","title":"Emotions in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Diagnostic Test: Carrying out a tests and questionnaires battery&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Lille Catholic University&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04804787?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-18T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":23,"discovery_date":"2021-03-15T14:45:21","title":"Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Clinically Isolated Syndrome&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: blood sample;   Biological: cerebro-spinal fluid&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    University Hospital, Bordeaux;   University of Bordeaux&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04798651?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-15T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":22,"discovery_date":"2021-03-15T14:45:21","title":"Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Providence Health &amp; Services&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04796584?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-15T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":21,"discovery_date":"2021-03-12T14:58:20","title":"Role of Individualized Versus Traditional Exercise in Combating Fatigue in Fatigued Multiple Sclerosis Patients","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Other: Adapted and individualized physical training program;   Other: traditional training program&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Centre Hospitalier Universitaire de Saint Etienne&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04796272?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-12T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":20,"discovery_date":"2021-03-11T12:25:31","title":"Post-COntrast 3D SE T1 Versus Coronal SE T1-WI MRI in Detecting Optic Neuritis (COCON)","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Optic Neuritis;   Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Diagnostic Test: Magnetic Resonance Imaging&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Fondation Ophtalmologique Adolphe de Rothschild&lt;br&#x2F;&gt;&lt;b&gt;Completed&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04793087?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-11T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":19,"discovery_date":"2021-03-11T12:25:31","title":"3D FLAIR Versus Coronal T2-WI MRI in Detecting Optic Neuritis (FLACON)","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Optic Neuritis;   Multiple Sclerosis;   Encephalopathy&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Diagnostic Test: Magnetic Resonance Imaging&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Fondation Ophtalmologique Adolphe de Rothschild&lt;br&#x2F;&gt;&lt;b&gt;Completed&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04792866?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-11T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":18,"discovery_date":"2021-03-11T12:25:30","title":"Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Secondary Progressive Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: BAF312;   Drug: Baseline disease modifying therapies (DMTs)&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Novartis Pharmaceuticals&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04792567?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-11T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":17,"discovery_date":"2021-03-09T14:59:53","title":"Open Label Randomized Multicenter to Assess Efficacy &amp; Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: Ofatumumab;   Drug: First line DMT&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Novartis Pharmaceuticals&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04788615?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-09T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":16,"discovery_date":"2021-03-09T14:59:53","title":"T Cell Profiling in Patients With Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Blood Sample&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Boston Children&#39;s Hospital&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04789551?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-09T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":15,"discovery_date":"2021-03-08T13:43:03","title":"Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis, Relapsing-Remitting;   Sexual Dysfunction&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Behavioral: Behavioural intervention for physical activity for multiple sclerosis (BIPAMS)&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    University of Alabama at Birmingham;   National Multiple Sclerosis Society&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04768777?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-24T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":14,"discovery_date":"2021-03-08T13:43:03","title":"miRNA Biomarkers in Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   miRNA;   Epigenetic;   Biomarker&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Genetic: miRNA&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    University of Gaziantep&lt;br&#x2F;&gt;&lt;b&gt;Completed&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04772495?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-26T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":13,"discovery_date":"2021-03-08T13:43:03","title":"Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis (MS)&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: At-home natalizumab treated MS patient&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Nantes University Hospital;   Rennes University Hospital&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04777539?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-02T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":12,"discovery_date":"2021-03-08T13:43:03","title":"ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Pediatric Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Behavioral: Physical Activity (PA) Intervention;   Behavioral: Waitlist attention-control&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    The Hospital for Sick Children;   Children&#39;s Hospital of Philadelphia;   University of Alabama at Birmingham;   Queen&#39;s University;   National Multiple Sclerosis Society&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04782466?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-04T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":11,"discovery_date":"2021-03-08T13:43:03","title":"Digital Gait Analysis in the Home Environment of Patients With Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    &lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Medical Valley Digital Health Application Center GmbH;   Celgene Corporation;   NeuroSys GmbH;   Fraunhofer Institute for Integrated Circuits IIS;   Portabiles HealthCare Technologies GmbH;   University of Regensburg&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04771858?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-25T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":10,"discovery_date":"2021-03-08T13:43:03","title":"Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Pathologic Processes;   Sclerosis;   Autoimmune Diseases of the Nervous System;   Demyelinating Autoimmune Diseases, CNS;   Autoimmune Diseases&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Behavioral: Standard Exercise Training;   Device: Phoenix Exoskeleton suit&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Sheffield Teaching Hospitals NHS Foundation Trust&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04786821?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-08T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":9,"discovery_date":"2021-03-08T13:43:03","title":"Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: Belimumab;   Drug: Short-course Ocrelizumab;   Drug: Continued Ocrelizumab&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Johns Hopkins University;   GlaxoSmithKline&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04767698?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-23T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":8,"discovery_date":"2021-03-08T13:43:03","title":"The Effect of Extra Virgin Olive Oil in People With Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Dietary Supplement: High Phenolic Extra Virgin Olive Oil&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    University of Cyprus;   World Olive Center for Health;   Ellis-Farm, Eliama Daily Value&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04787497?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-08T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":7,"discovery_date":"2021-03-08T12:17:02","title":"Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Mavenclad®&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04783935?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-05T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":6,"discovery_date":"2021-03-08T12:17:02","title":"Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension)","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Mavenclad®&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04776213?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-01T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":5,"discovery_date":"2021-03-02T14:12:09","title":"COVID-19: SARS Vaccination","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    SARS-CoV Infection;   COVID-19;   Allergic Reaction;   Mast Cell Disorder;   Non-atopic&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: Moderna COVID-19 Vaccine;   Biological: Pfizer-BioNTech COVID-19 Vaccine;   Biological: Placebo&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN);   Rho Federal Systems Division, Inc.&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04761822?term&#x3D;biontech&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-21T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":4,"discovery_date":"2021-03-01","title":"Antibody Response to COVID-19 Vaccines in Liver Disease Patients","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Chronic Liver Disease&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: BNT162b2;   Biological: CoronaVac;   Biological: AZD1222&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Humanity &amp; Health Medical Group Limited&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04775069?term&#x3D;biontech&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-01T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":3,"discovery_date":"2021-02-27","title":"Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    SARS-CoV-2 Infection;   COVID-19;   Maternal Immunization&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: BNT162b2;   Other: Placebo&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    BioNTech SE;   Pfizer&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04754594?term&#x3D;biontech&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-15T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":2,"discovery_date":"2021-02-27","title":"National Cohort Study of Effectiveness and Safety of SARS-CoV-2&#x2F;COVID-19 Vaccines (ENFORCE)","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    SARS-CoV Infection&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: COMIRNATY - BioNTech Manufacturing GmbH;   Biological: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH;   Biological: COVID-19 Vaccine AstraZeneca suspension for injection&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Jens D Lundgren, MD;   Ministry of the Interior and Health, Denmark&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04760132?term&#x3D;biontech&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-18T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":1,"discovery_date":"2021-02-27","title":"COVID-19: SARS Vaccination Reactions","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    SARS-CoV Infection;   COVID-19;   Allergic Reaction;   Mast Cell Disorder;   Non-atopic&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: Moderna COVID-19 Vaccine;   Biological: Pfizer-BioNTech COVID-19 Vaccine;   Biological: Placebo&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN);   Rho Federal Systems Division, Inc.&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04761822?term&#x3D;biontech&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-21T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null}]